| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/24/2002 | EP1224180A2 Substituted azoles |
| 07/24/2002 | EP1224179A2 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/24/2002 | EP1224175A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224174A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224170A1 6-position substituted indoline, production and use thereof as a medicament |
| 07/24/2002 | EP1224163A1 Use of carbonylamino derivatives against cns disorders |
| 07/24/2002 | EP1223968A2 Use of urodilatin for treating chronic kidney failure with residual kidney functions |
| 07/24/2002 | EP1223961A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 07/24/2002 | EP1223941A2 Therapeutic treatments comprising administratoin of certain steroids for blood cell deficiencies |
| 07/24/2002 | EP0904110B1 Nitric oxide donors capable of reducing toxicity from drugs |
| 07/24/2002 | CN1360583A Novel compounds, their use and preparation |
| 07/24/2002 | CN1360572A Vitamin D3 Analogs |
| 07/24/2002 | CN1360502A Use of dopamine D3 receptor ligands for producing medicaments for treating kidney disorders |
| 07/24/2002 | CN1359717A Process for prepairng Chinese-medicinal ointment of treating uremia, renal hypertension and hyperlipomia |
| 07/24/2002 | CN1359707A Chinese medicine for treating naphritis |
| 07/24/2002 | CN1359703A Oral liquid for detoxicating and dispelling wind |
| 07/24/2002 | CN1087944C Medicinal capsule for removing kidney stone |
| 07/23/2002 | US6423840 Forming n-acylamino compound |
| 07/23/2002 | US6423729 Therapeutic or prophylactic agent for glomerulopathy |
| 07/23/2002 | US6423713 Substituted pyrazoles as p38 kinase inhibitors |
| 07/23/2002 | US6423710 Cyclic AMP-specific phosphodiesterase inhibitors |
| 07/23/2002 | US6423708 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/23/2002 | CA2365997A1 Novel polypeptide |
| 07/23/2002 | CA2041594C Pyrido[2,3-f][1,4]thiazepines and pyrido[3,2-b][1,5]benzothiazepines |
| 07/18/2002 | WO2002056022A2 Diagnostics, drug screening and treatment for cancer |
| 07/18/2002 | WO2002055706A2 Asip-related proteins |
| 07/18/2002 | WO2002055694A2 Discriminative nucleic acid analysis using clone sequence signatures |
| 07/18/2002 | WO2002055541A2 Peptides having inhibiting activity on the production of nitric oxide |
| 07/18/2002 | WO2002055532A2 Variant growth hormone molecules conjugated with macromolecular compounds |
| 07/18/2002 | WO2002055523A1 Mikanolide derivatives, their preparation and therapeutic uses |
| 07/18/2002 | WO2002055517A2 4-(hetero)aryl substituted indolinones |
| 07/18/2002 | WO2002055514A2 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 07/18/2002 | WO2002055510A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 07/18/2002 | WO2002055498A1 Pharmaceutically active piperidine derivatives |
| 07/18/2002 | WO2002055087A1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 07/18/2002 | WO2002055077A1 Use of imidazolyl cyclic acetal derivatives in the manufacture of a medicament for the treatment of diseases mediated by the alk5 receptors |
| 07/18/2002 | WO2002055067A2 Fumaric acid derivatives as nf-kappab inhibitors |
| 07/18/2002 | WO2002055066A1 Fumaric acid derivatives as nf-kappa-b inhibitors |
| 07/18/2002 | WO2002055063A2 Fumaric acid amides |
| 07/18/2002 | WO2002055016A2 INHIBITION OF NF-λB BY TRITERPENE COMPOSITIONS |
| 07/18/2002 | WO2002032876A3 Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence |
| 07/18/2002 | WO2002022558A3 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 07/18/2002 | WO2002016310A9 Selective androgen receptor modulators and methods of use thereof |
| 07/18/2002 | WO2002011704A3 Use of aryl-substituted 1,1-diphosphonates for the treatment of bone diseases |
| 07/18/2002 | WO2002003989A3 Use of substituted indole compounds for treating sphincter incontinence |
| 07/18/2002 | WO2002003912A3 Novel c-4 substituted retinoids |
| 07/18/2002 | WO2002002633A3 Transporters and ion channels |
| 07/18/2002 | WO2001094391A3 Intracellular signaling proteins |
| 07/18/2002 | WO2001094345A3 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 07/18/2002 | WO2001090103A3 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 07/18/2002 | WO2001083525A3 Modified peptides, comprising an fc domain, as therapeutic agents |
| 07/18/2002 | WO2001083480A3 Dihydropyridine compounds and methods of use |
| 07/18/2002 | WO2001082920A3 Treatment of congestive heart failure with a composition comprising a diuretic agent and a vasopressin antagonist |
| 07/18/2002 | WO2001081590A3 Protein phosphatases |
| 07/18/2002 | WO2001079282A3 Molecules associated with human reproduction |
| 07/18/2002 | WO2001072728A3 Novel piperazine derivatives |
| 07/18/2002 | WO2001062263A3 Use of pentosan polysulfate for the manufacture of a medicament for the treatment of male chronic pelvic pain syndrome |
| 07/18/2002 | WO2001049295A9 Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification |
| 07/18/2002 | WO2001005834A9 Human tumor necrosis factor receptors tr13 and tr14 |
| 07/18/2002 | US20020094987 Amide or thioamide substituted benzimidazole or quinoxaline derivatives; therapeutic utility via inhibition of tumor necrosis factor or phosphodiesterase |
| 07/18/2002 | US20020094980 Preparing 1,1-dioxo-2-phenyl-3-carboxy-4-phenyl-1,2-benzo(e)-thiazines by a five-step process starting with a (2-(methyl-oxycarbonyl-)phenyl-sulfonamido-)benzene; alkylation; cyclization; hydroxylation; esterification and coupling |
| 07/18/2002 | US20020094328 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 07/18/2002 | DE10102048A1 Use of active antithrombin III having endothelial cell proliferation inhibitory activity for combating diseases associated with angiogenesis, e.g. retinopathy, neuropathy, leprosy and cancer |
| 07/18/2002 | CA2776023A1 Fumaric acid amides |
| 07/18/2002 | CA2434042A1 Asip-related proteins |
| 07/18/2002 | CA2433981A1 Mikanolide derivatives, their preparation and therapeutic uses |
| 07/18/2002 | CA2433449A1 Metabolic gene polynucleotides and polypeptides and uses thereof |
| 07/18/2002 | CA2432114A1 4-(hetero)aryl substituted indolinones |
| 07/18/2002 | CA2430060A1 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer |
| 07/18/2002 | CA2429177A1 Inhibition of nf-.kappa.b by triterpene compositions |
| 07/18/2002 | CA2428075A1 Fumaric acid derivatives as nf-kappab inhibitors |
| 07/17/2002 | EP1223170A1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof |
| 07/17/2002 | EP1222463A2 Allosteric sites on muscarinic receptors |
| 07/17/2002 | EP1222275A2 Serum amyloid a isoform from colostrum |
| 07/17/2002 | EP1222273A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 07/17/2002 | EP1222266A2 Pca3 messenger rna species in benign and malignant prostate tissues |
| 07/17/2002 | EP1222253A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 07/17/2002 | EP1222191A2 Benzodiazepin derivatives, the production and use thereof |
| 07/17/2002 | EP1222183A1 Benzopyran derivatives |
| 07/17/2002 | EP1222171A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 07/17/2002 | EP1221955A2 Immunostimulatory nucleic acids |
| 07/17/2002 | EP1221908A1 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| 07/17/2002 | EP0888340B1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 07/17/2002 | EP0888298B1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 07/17/2002 | EP0830374B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 07/17/2002 | CN1359392A Coupled compound of erythropoietin with glycol |
| 07/17/2002 | CN1359381A Thiazole-derivaties |
| 07/17/2002 | CN1359376A Carboxylic acid derivatives compriosing aryl-substituted nitrogen heterocycles, their production and their use as endothel in receptor antagonists |
| 07/17/2002 | CN1359300A Uro-genital condition treatment system |
| 07/17/2002 | CN1359288A Method for improvement of transport across adaptable semi-permeable barriers |
| 07/17/2002 | CN1358514A Medicine for treating kidney disease and method for preparing same |
| 07/17/2002 | CN1358513A Medicine for treating various kinds of kidney disease |
| 07/17/2002 | CN1358503A Fossil cold-dispelling tea |
| 07/17/2002 | CN1087615C Shenkangsan-medicine for treating nephrosis |
| 07/17/2002 | CA2367825A1 Antithrombin iii for disorders caused by angiogenesis |
| 07/16/2002 | US6420567 Prodrugs |
| 07/16/2002 | US6420408 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 07/16/2002 | US6420383 Calcium channel blockers, hypersensitivity, allergy, asthma, bronchospasm, dysmenorrhea, esophageal spasm, glaucoma, premature labor, urinary tract disorders, gastrointestinal motility disorders and cardiovascular disorders. |
| 07/16/2002 | US6420342 Ribose, folic acid, orotic acid |
| 07/16/2002 | US6420341 Treating vasoconstrictor and hypertension effects in warm-blooded animals |